FGF2 and Miyoshi myopathy: In multiple myeloma (MM), PTX3 affects in vitro and in vivo fibroblast growth factor 2-mediated MM angiogenesis, promoting cytotoxicity in MM cells by inhibiting the cross-talk between plasma cells, endothelial cells and fibroblasts [39].